The lipid raft-anchored adaptor protein Cbp controls the oncogenic potential of c-Src

Chitose Oneyama1, Tomoya Hikita, Kengo Enya

  • 1Department of Oncogene Research, Research Institute for Microbial Diseases, Osaka University, 3-1 Yamadaoka, Suita, Osaka 565-0871, Japan.

Molecular Cell
|May 24, 2008
PubMed

Insights

Cbp acts as a tumor suppressor by binding to and sequestering the oncogenic tyrosine kinase c-Src in lipid rafts, independent of Csk. Restoring Cbp levels inhibits c-Src-driven cancer progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • The tyrosine kinase c-Src is frequently upregulated in human cancers, contributing to oncogenicity.
  • The precise regulatory mechanisms controlling c-Src's oncogenic potential, particularly its interaction with regulators like Csk, remain incompletely understood.

Purpose of the Study:

  • To investigate the role of the Csk adaptor Cbp/PAG in regulating the oncogenic activity of c-Src.
  • To elucidate the mechanism by which Cbp influences c-Src-mediated transformation and tumorigenesis.

Main Methods:

  • Utilized Csk-deficient cells for studying c-Src transformation.
  • Assessed the impact of Cbp expression levels on c-Src transformation and tumorigenesis.
  • Investigated the interaction between phosphorylated Cbp and activated c-Src in lipid rafts.
  • Examined Cbp expression in human cancer cells and tumors.

Main Results:

  • c-Src activation downregulates Cbp expression; Cbp re-expression suppresses c-Src transformation and tumorigenesis.
  • Cbp-deficient cells exhibit increased susceptibility to v-Src transformation.
  • Phosphorylated Cbp binds activated c-Src, sequestering it within lipid rafts, thereby inhibiting c-Src function independently of Csk.
  • Cbp is downregulated in some human cancers, and its introduction suppresses tumor growth.

Conclusions:

  • Cbp functions as a critical suppressor of c-Src oncogenic activity.
  • Cbp sequesters activated c-Src in lipid rafts, providing a Csk-independent regulatory mechanism.
  • Cbp represents a potential therapeutic target for inhibiting c-Src-mediated tumor progression.

Related Concept Videos

Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Catenins01:23

Catenins

Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...